Chiropractic’s Next Big Challenge
Chiropractic’s Next Big Challenge
Chiropractic’s Next Big Challenge
It’s time for us to lead the charge to help NIH see the need to fund Musculoskeletal research based on how much low-quality management of MSK care has cost our economy. It won’t last forever, just long enough to change the thinking on the ground, with Insurers and at the State and Federal levels.
READ THIS ARTICLE NOW!
![]() |
Musculoskeletal Health: An Ecological Study Assessing Disease Burden and Research Funding Before undertaking this study, we conducted an extensive literature review to identify existing evidence related to the relationship between disease burden and research funding, particularly focusing on the National Institutes of Health (NIH) and the Global Burden of Disease (GBD) data. Disease Burden is measured by 3 characteristics: • Years Lived with Disability (YLDs), • Years of Life Lost (YLLs) The goal was to gather insights into the existing body of knowledge surrounding disease burden and research funding disparities to inform our ecological study design and analysis methodology. Implications of all the available evidence Global health morbidity has shifted in recent decades from As death rates have declined, non-fatal injuries and NCDs have become a significant concern for health systems. When rerviewing the 2019 disease burden (measured in DALYs) and 2021 A DALY (Disability-Adjusted Life Year) is a measure of health burden, including both reduction in life expectancy and diminished quality of life. More specifically, the DALY burden for a particular condition is the sum of YLL (years of life lost due to premature mortality) and YLD (years lost to disability). However, in the 2021 NIH funding, all musculoskeletal diseases were underfunded, compared to their societal/economic burden, with low back pain receiving the least relative funding, at $496.4 million less funding than was predicted. Predicted funding levels were derived to assess the adequacy of funding for various diseases. Subsequently, the ratios of actual to predicted 2021 NIH funding for diseases characterized as underfunded (where the ratio <1) were determined. Musculoskeletal diseases were underfunded relative to their disease burden, with neck pain receiving the least funding at 0.83% of the predicted amount. Low back pain, osteoarthritis, and rheumatoid arthritis were underfunded at 13.88%, 35.08%, and 66.26% of predicted amounts, respectively. To be commensurate with their actual total burden, funding for neck pain, low back pain, and osteoarthritis would need to increase 120–fold, 7–fold, and 3–fold, respectively.
|




